About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Aug 07, 2023...
REHOVOT, ISRAEL — August 8, 2023—Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that allow them to evade the medications’ therapeutic effect.
In research published today in the journal Cell Reports Medicine, investigators from the Weizmann Institute of Science report findings that may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists identified a biomarker that may help physicians treat select lung cancer patients with a single antibody-based drug that is likely to bring about full remission, without cancer relapse.
Aug 08, 2023...
To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, operate in stealth and cannot be targeted by the body’s regular immune system.
Edity Therapeutics, an Israeli startup founded in 2019, reprograms a patient’s own immune cells, giving them the ability to hunt down and destroy these cancer cells. It’s like transforming regular beat cops into lethal supersleuths.
Aug 08, 2023... Israeli study finds biological treatment effective for lung cancer
Dec 02, 2023... REHOVOT, ISRAEL—December 2, 2023— Enamel, the hardest and most mineral-rich substance in the human body, covers and protects our teeth. But in one of every 10 people – and one-third of children with celiac disease – this layer appears defective, failing to protect the teeth properly. As a result, teeth become more sensitive to heat, cold and sour food, and they may decay faster. In most cases, the cause of the faulty enamel production is unknown.
Mar 26, 2024...
Jerusalem, March 26, 2024 – The Blavatnik Family Foundation, the Israel Academy of Sciences and Humanities and The New York Academy of Sciences announced today the Laureates of the 2024 Blavatnik Awards for Young Scientists in Israel. This year’s Laureates, who will each receive $100,000, are:
Schraga Schwartz, PhD (Life Sciences) – Weizmann Institute of Science – Recognized for developing groundbreaking analytical methods to locate and quantify chemical changes in RNA. Professor Schwartz’s breakthroughs in understanding RNA modifications hold promise for treating genetic diseases and expanding the role of RNA editing beyond vaccine development.